1. Home
  2. LUV vs BBIO Comparison

LUV vs BBIO Comparison

Compare LUV & BBIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Southwest Airlines Company

LUV

Southwest Airlines Company

HOLD

Current Price

$38.68

Market Cap

18.9B

ML Signal

HOLD

Logo BridgeBio Pharma Inc.

BBIO

BridgeBio Pharma Inc.

HOLD

Current Price

$75.92

Market Cap

15.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LUV
BBIO
Founded
1967
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
18.9B
15.9B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
LUV
BBIO
Price
$38.68
$75.92
Analyst Decision
Hold
Strong Buy
Analyst Count
18
25
Target Price
$45.37
$86.33
AVG Volume (30 Days)
3.9M
1.9M
Earning Date
04-22-2026
05-12-2026
Dividend Yield
1.93%
N/A
EPS Growth
3.95
N/A
EPS
0.92
N/A
Revenue
N/A
$502,076,000.00
Revenue This Year
$16.57
$89.45
Revenue Next Year
$3.61
$73.78
P/E Ratio
$42.03
N/A
Revenue Growth
N/A
126.26
52 Week Low
$29.26
$48.78
52 Week High
$55.11
$93.42

Technical Indicators

Market Signals
Indicator
LUV
BBIO
Relative Strength Index (RSI) 35.74 39.14
Support Level $37.44 $70.65
Resistance Level $42.03 $79.13
Average True Range (ATR) 0.97 2.10
MACD 0.02 -0.59
Stochastic Oscillator 28.29 24.81

Price Performance

Historical Comparison
LUV
BBIO

About LUV Southwest Airlines Company

Southwest Airlines is the largest domestic air carrier in the United States by passengers boarded. Southwest operates nearly 800 aircraft in an all-Boeing 737 fleet. Despite offering some longer routes and a few perks for business travelers, the airline predominantly specializes in short-haul, leisure flights operated with a simple cabin configuration in a point-to-point network. In early 2026, Southwest modified its cabins to offer some rows with extra legroom, its ticketing process and merchandising to offer assigned seats, and more fare categories to include a basic economy class that appears for the first time in travel aggregators' search results and more directly competes with other airlines' offerings.

About BBIO BridgeBio Pharma Inc.

BridgeBio Pharma is a biotechnology company focused on discovering, developing, testing, and delivering transformative treatments for patients with genetic diseases. The company has four programs in its late-stage pipeline focusing on Mendelian disorders, oncology, and gene therapy. One of its key programs, Attruby (acoramidis), is an orally administered small molecule designed to stabilize tetrameric transthyretin for the treatment of transthyretin amyloid cardiomyopathy.

Share on Social Networks: